PROTUNE Trademark

Trademark Overview


On Tuesday, November 30, 2021, a trademark application was filed for PROTUNE with the United States Patent and Trademark Office. The USPTO has given the PROTUNE trademark a serial number of 97149061. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Friday, December 6, 2024. This trademark is owned by Catalyst Biosciences, Inc.. The PROTUNE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the field of biotechnology; pharmaceutical research into new drugs and development of drugs; scientific and technical research services in the field of biotechnology, hematology, blood disorders, neurology, inflammation, immunology, oncology, skin disorders, autoimmune disease, infectious diseases and genetic diseases; industrial analysis and research services in the field of biotechnology, hematology, neurology, inflammation, immunology, oncology, skin disorders, autoimmune disease, infectious diseases and genetic diseases; providing information and advice in relation to the aforementioned services, namely, providing scientific information and advice relating to biotechnology, pharmaceutical research, and scientific and technical research; providing scientific and medical research information in the field of pharmaceuticals; pharmaceutical research and development services; product research and development services
protune

General Information


Serial Number97149061
Word MarkPROTUNE
Filing DateTuesday, November 30, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateFriday, December 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 18, 2022

Trademark Statements


Pseudo MarkPRO TUNE
Goods and ServicesResearch and development in the field of biotechnology; pharmaceutical research into new drugs and development of drugs; scientific and technical research services in the field of biotechnology, hematology, blood disorders, neurology, inflammation, immunology, oncology, skin disorders, autoimmune disease, infectious diseases and genetic diseases; industrial analysis and research services in the field of biotechnology, hematology, neurology, inflammation, immunology, oncology, skin disorders, autoimmune disease, infectious diseases and genetic diseases; providing information and advice in relation to the aforementioned services, namely, providing scientific information and advice relating to biotechnology, pharmaceutical research, and scientific and technical research; providing scientific and medical research information in the field of pharmaceuticals; pharmaceutical research and development services; product research and development services

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, September 13, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVERTEX PHARMACEUTICALS INCORPORATED
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressBOSTON, MA 02210

Party NameCatalyst Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameCatalyst Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Tuesday, September 13, 2022EXAMINERS AMENDMENT E-MAILED
Friday, December 3, 2021NEW APPLICATION ENTERED
Friday, December 3, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 8, 2022ASSIGNED TO EXAMINER
Tuesday, September 13, 2022EXAMINERS AMENDMENT -WRITTEN
Tuesday, September 13, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 13, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, September 13, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 28, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 18, 2022PUBLISHED FOR OPPOSITION
Tuesday, October 18, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 13, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 8, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, May 9, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 9, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 9, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 9, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 9, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 8, 2023SOU TEAS EXTENSION RECEIVED
Thursday, June 8, 2023SOU EXTENSION 1 FILED
Thursday, June 8, 2023SOU EXTENSION 1 GRANTED
Saturday, June 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 23, 2023SOU TEAS EXTENSION RECEIVED
Monday, October 23, 2023SOU EXTENSION 2 FILED
Monday, October 23, 2023SOU EXTENSION 2 GRANTED
Wednesday, October 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, April 21, 2024SOU TEAS EXTENSION RECEIVED
Sunday, April 21, 2024SOU EXTENSION 3 FILED
Sunday, April 21, 2024SOU EXTENSION 3 GRANTED
Tuesday, April 23, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 6, 2024SOU TEAS EXTENSION RECEIVED
Friday, December 6, 2024SOU EXTENSION 4 FILED
Friday, December 6, 2024SOU EXTENSION 4 GRANTED
Wednesday, June 4, 2025SOU TEAS EXTENSION RECEIVED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED